Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial

BACKGROUND: The Shexiang Baoxin Pill (MUSKARDIA) has been used for treating coronary artery disease (CAD) and angina for more than 30 years in China. Nevertheless, methodologically sound trials on the use of MUSKARDIA in CAD patients are scarce. The aim of the study is to determine the effects of MU...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Jun-Bo, Fan, Wei-Hu, Zhou, Jing-Min, Shi, Hai-Ming, Ji, Fu-Sui, Wu, Yang, Zhao, Yu-Lan, Qian, Jun, Jin, Yuan-Zhe, Liu, Ying-Wu, Wang, Sheng-Huang, He, Sheng-Hu, Yang, Ping, Wu, Jie, Lu, Feng, Hou, Zi-Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817287/
https://www.ncbi.nlm.nih.gov/pubmed/33273369
http://dx.doi.org/10.1097/CM9.0000000000001257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817287/
https://www.ncbi.nlm.nih.gov/pubmed/33273369
http://dx.doi.org/10.1097/CM9.0000000000001257

Ejemplares similares